Improving on R-ICE in relapsed DLBCL
- PMID: 29674349
- DOI: 10.1182/blood-2018-02-832147
Improving on R-ICE in relapsed DLBCL
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Comment on
-
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.Blood. 2018 Apr 19;131(16):1805-1808. doi: 10.1182/blood-2017-08-802561. Epub 2018 Jan 31. Blood. 2018. PMID: 29386196 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources